Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response

Open access

Abstract

Clear cell renal cell carcinoma (ccRCC) has a high metastatic rate, and its incidence and mortality are still rising. The aim of this study was to identify the key tumor-infiltrating immune cells (TIICs) affecting the distant metastasis and prognosis of patients with ccRCC and to construct a relevant prognostic panel to predict immunotherapy response. Based on ccRCC bulk RNA sequencing data, resting mast cells (RMCs) were screened and verified using the CIBERSORT algorithm, survival analysis, and expression analysis. Distant metastasis-associated genes were identified using single-cell RNA sequencing data. Subsequently, a three-gene (CFB, PPP1R18, and TOM1L1) panel with superior distant metastatic and prognostic performance was established and validated, which stratified patients into high- and low-risk groups. The high-risk group exhibited lower infiltration of RMCs, higher tumor mutation burden (TMB), and worse prognosis. Therapeutically, the high-risk group was more sensitive to anti-PD-1 and anti-CTLA-4 immunotherapy, whereas the low-risk group displayed a better response to anti-PD-L1 immunotherapy. Furthermore, two immune clusters revealing distinct immune, clinical, and prognosis heterogeneity were distinguished. Immunohistochemistry of ccRCC samples verified the expression patterns of the three key genes. Collectively, the prognostic panel based on RMCs is able to predict distant metastasis and immunotherapy response in patients with ccRCC, providing new insight for the treatment of advanced ccRCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells12010180

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Workflow of the study. Turquoise rectangles represent the identification of key resting mast cells (RMCs). Green rectangles indicate screening of distant metastatic marker genes. Purple rectangles represent functional enrichment analysis of resting mast-cell-sensitive genes (RMSGs). Blue rectangles indicate the construction of the 3-DMA-RMSG prognostic panel. Red rectangles represent external validation of the 3-DMA-RMSG prognostic panel. Orange rectangles exhibit the predictive value and biological function of the 3-DMA-MRSG panel.
Figure 1 Workflow of the study. Turquoise rectangles represent the identification of key resting mast cells (RMCs). Green rectangles indicate screening of distant metastatic marker genes. Purple rectangles represent functional enrichment analysis of resting mast-cell-sensitive genes (RMSGs). Blue rectangles indicate the construction of the 3-DMA-RMSG prognostic panel. Red rectangles represent external validation of the 3-DMA-RMSG prognostic panel. Orange rectangles exhibit the predictive value and biological function of the 3-DMA-MRSG panel.CC BY · PubMed Central
Figure 2 Identification and validation of the key TIICs. (A) The landscape depicts the proportions of TIICs in each ccRCC tissue. (B) Box plot describes the level of infiltration for the 22 TIICs. (C) Distribution of the top ten abundant TIICs between nondistant metastasis and distant metastasis ccRCC samples. Survival plots for OS (D) and PFS (E) display the prognostic value of RMCs. (F) Distribution of the number of RMCs between normal kidney tissues and ccRCC tissues. Violin plot visualizes the infiltration level of RMCs according to T stage (G), pathological stage (H), and histological grade (I). * p < 0.05, ** p < 0.01; ns, no significance.
Figure 2 Identification and validation of the key TIICs. (A) The landscape depicts the proportions of TIICs in each ccRCC tissue. (B) Box plot describes the level of infiltration for the 22 TIICs. (C) Distribution of the top ten abundant TIICs between nondistant metastasis and distant metastasis ccRCC samples. Survival plots for OS (D) and PFS (E) display the prognostic value of RMCs. (F) Distribution of the number of RMCs between normal kidney tissues and ccRCC tissues. Violin plot visualizes the infiltration level of RMCs according to T stage (G), pathological stage (H), and histological grade (I). * p < 0.05, ** p < 0.01; ns, no significance.CC BY · PubMed Central
Figure 3 Screening and verification of DEGs. Volcano plots of DEGs between normal and ccRCC tissues based on TCGA (A) and ICGC datasets (B). Venn diagrams showing screened common downregulated (C) and upregulated DEGs (D). (E) Heat map of DEGs among several clinical phenotypes. DEGs, differentially expressed genes.
Figure 3 Screening and verification of DEGs. Volcano plots of DEGs between normal and ccRCC tissues based on TCGA (A) and ICGC datasets (B). Venn diagrams showing screened common downregulated (C) and upregulated DEGs (D). (E) Heat map of DEGs among several clinical phenotypes. DEGs, differentially expressed genes.CC BY · PubMed Central
Figure 4 Identification and validation of the key modules closely related to RMCs. (A) Hierarchical clustering tree of DEGs based on the TCGA dataset. (B) Cluster dendrogram and heat map of the module eigengenes. (C) Heat map describing the relationship between the module eigengenes and the infiltration of the top ten TIICs. (D) Scatter plot of gene significance for RMCs vs. module membership in the key blue module.
Figure 4 Identification and validation of the key modules closely related to RMCs. (A) Hierarchical clustering tree of DEGs based on the TCGA dataset. (B) Cluster dendrogram and heat map of the module eigengenes. (C) Heat map describing the relationship between the module eigengenes and the infiltration of the top ten TIICs. (D) Scatter plot of gene significance for RMCs vs. module membership in the key blue module.CC BY · PubMed Central
Figure 5 Functional enrichment analysis of RMSGs in the blue module. (A) Tree map of the top 20 most significant pathways in KEGG enrichment analysis. (B) The top 20 most significant GO terms and relevant genes in biological process are presented. (C) The chord diagram displays the top 20 most significant GO terms and involved genes in cell components. (D) The circle plot shows the top 20 most significant GO terms in molecular function. (E) Network interaction analysis of the signaling pathways using the Metascape database. (F) PPI network of RMSGs. RMSGs, resting mast-cell-sensitive genes; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, gene ontology; PPI, protein–protein interaction.
Figure 5 Functional enrichment analysis of RMSGs in the blue module. (A) Tree map of the top 20 most significant pathways in KEGG enrichment analysis. (B) The top 20 most significant GO terms and relevant genes in biological process are presented. (C) The chord diagram displays the top 20 most significant GO terms and involved genes in cell components. (D) The circle plot shows the top 20 most significant GO terms in molecular function. (E) Network interaction analysis of the signaling pathways using the Metascape database. (F) PPI network of RMSGs. RMSGs, resting mast-cell-sensitive genes; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, gene ontology; PPI, protein–protein interaction.CC BY · PubMed Central
Figure 6 Single-cell RNA sequencing data in GSE73121 and DMA−RMSGs screening. (A) Quality control was performed to filter the ccRCC cells with poor quality. (B) Scatter plot shows a positive correlation between gene counts and sequencing depth. (C) Genes with high variability across cells were identified using a characteristic variance plot. (D) The two distinct distributions of ccRCC cell groups were obtained using the PCA method. (E) Significant principal components were screened using the estimated p-value. (F) ccRCC cells were further classified into two subgroups using the t-SNE algorithm. (G) Heat map displays the independent expression patterns of the top 30 DMAGs between the two subgroups. (H) Key DMA-RMSGs were obtained according to the intersection of RMSGs and DMAGs. (I) Dot plot presents the differential expression levels of the 17 DMA-RMSGs between the two ccRCC clusters.
Figure 6 Single-cell RNA sequencing data in GSE73121 and DMA−RMSGs screening. (A) Quality control was performed to filter the ccRCC cells with poor quality. (B) Scatter plot shows a positive correlation between gene counts and sequencing depth. (C) Genes with high variability across cells were identified using a characteristic variance plot. (D) The two distinct distributions of ccRCC cell groups were obtained using the PCA method. (E) Significant principal components were screened using the estimated p-value. (F) ccRCC cells were further classified into two subgroups using the t-SNE algorithm. (G) Heat map displays the independent expression patterns of the top 30 DMAGs between the two subgroups. (H) Key DMA-RMSGs were obtained according to the intersection of RMSGs and DMAGs. (I) Dot plot presents the differential expression levels of the 17 DMA-RMSGs between the two ccRCC clusters.CC BY · PubMed Central
Figure 7 Identification and validation of the DMA-RMSGs that independently predict ccRCC prognosis. (A) Heat map of the correlations among the 17 DMA-RMSGs. (B) Heat map of the relationship among the 16 key DMA-RMSGs. (C) Univariate Cox regression analysis of the DMA-RMSGs. (D,E) LASSO regression analysis of the TCGA cohort. (F) Multivariate Cox regression analysis identified the coefficient of the three key DMA-RMSGs. Raincloud plots display the significantly distinct expression levels of CFB (G), PPP1R18 (H), and TOM1L1 (I) between nondistant and distant metastasis samples (p < 0.001). The independent expression patterns of CFB (J), PPP1R18 (K), and TOM1L1 (L) between normal and tumor tissues. The expression levels of CFB (M), PPP1R18 (N), and TOM1L1 (O) were significantly associated with the pathological stage (p < 0.001). Expression patterns of CFB (P), PPP1R18 (Q), and TOM1L1 (R) were significantly linked with the histological grade (p < 0.001). Survival analysis of DFS for CFB (S), PPP1R18 (T), and TOM1L1 (U).
Figure 7 Identification and validation of the DMA-RMSGs that independently predict ccRCC prognosis. (A) Heat map of the correlations among the 17 DMA-RMSGs. (B) Heat map of the relationship among the 16 key DMA-RMSGs. (C) Univariate Cox regression analysis of the DMA-RMSGs. (D,E) LASSO regression analysis of the TCGA cohort. (F) Multivariate Cox regression analysis identified the coefficient of the three key DMA-RMSGs. Raincloud plots display the significantly distinct expression levels of CFB (G), PPP1R18 (H), and TOM1L1 (I) between nondistant and distant metastasis samples (p < 0.001). The independent expression patterns of CFB (J), PPP1R18 (K), and TOM1L1 (L) between normal and tumor tissues. The expression levels of CFB (M), PPP1R18 (N), and TOM1L1 (O) were significantly associated with the pathological stage (p < 0.001). Expression patterns of CFB (P), PPP1R18 (Q), and TOM1L1 (R) were significantly linked with the histological grade (p < 0.001). Survival analysis of DFS for CFB (S), PPP1R18 (T), and TOM1L1 (U).CC BY · PubMed Central
Figure 8 Identification and verification of novel immune subtypes in ccRCC. (A) The optimal k value for unsupervised clustering was determined according to the cumulative distribution function curve. (B) Sample clustering heat map exhibiting the consensus matrix in ccRCC. Stratification into two independent clusters verified by the PCA algorithm (C) and t−SNE algorithm (D). Kaplan–Meier curves for OS (E) and progression−free survival (F) between two ccRCC subtypes. (G) Clustering heat map representing the relationship between 2 subtypes and 12 prognosis−related DMA−RMSGs. Distribution of C1 and C2 among metastasis (H), stage (I), grade (J), tumor mutation burden (K), gender (L), and age (M) in ccRCC. Differential infiltration fractions of 22 TIICs between the two ccRCC clusters shown in violin plots (N) and a heat map (O).
Figure 8 Identification and verification of novel immune subtypes in ccRCC. (A) The optimal k value for unsupervised clustering was determined according to the cumulative distribution function curve. (B) Sample clustering heat map exhibiting the consensus matrix in ccRCC. Stratification into two independent clusters verified by the PCA algorithm (C) and t−SNE algorithm (D). Kaplan–Meier curves for OS (E) and progression−free survival (F) between two ccRCC subtypes. (G) Clustering heat map representing the relationship between 2 subtypes and 12 prognosis−related DMA−RMSGs. Distribution of C1 and C2 among metastasis (H), stage (I), grade (J), tumor mutation burden (K), gender (L), and age (M) in ccRCC. Differential infiltration fractions of 22 TIICs between the two ccRCC clusters shown in violin plots (N) and a heat map (O).CC BY · PubMed Central
Figure 9 Evaluation and investigation of the prognostic panel. (A) OS analysis in the high- and low-risk groups. Time-dependent ROC curve (B) and DCA curve (C) of the risk score model. (D) Distribution of the risk scores of each patient with ccRCC in the TCGA set. (E) Survival status of patients with ccRCC with elevated risk scores. (F) Risk scores of patients with ccRCC were significantly correlated with distant metastasis (p < 0.001). (G) The independent expression distribution of the high- and low-risk groups was assessed using principal component analysis. (H) Heat map depicts the differential expression of the three key DMA-RMSGs between high- and low-risk patients. (I) The relationship between clinical traits and risk scores in TCGA. Pan-cancer analysis of KIAA1949/PPP1R18 (J), CFB (K), and TOM1L1 (L). The GSEA network revealed the pathways enriched in low-risk patients (M) and high-risk patients (N). Representative gene sets are labeled with a red outline. p < 0.05 was considered statistically significant. ROC, receiver operating characteristic; DCA, decision curve analysis. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 9 Evaluation and investigation of the prognostic panel. (A) OS analysis in the high- and low-risk groups. Time-dependent ROC curve (B) and DCA curve (C) of the risk score model. (D) Distribution of the risk scores of each patient with ccRCC in the TCGA set. (E) Survival status of patients with ccRCC with elevated risk scores. (F) Risk scores of patients with ccRCC were significantly correlated with distant metastasis (p < 0.001). (G) The independent expression distribution of the high- and low-risk groups was assessed using principal component analysis. (H) Heat map depicts the differential expression of the three key DMA-RMSGs between high- and low-risk patients. (I) The relationship between clinical traits and risk scores in TCGA. Pan-cancer analysis of KIAA1949/PPP1R18 (J), CFB (K), and TOM1L1 (L). The GSEA network revealed the pathways enriched in low-risk patients (M) and high-risk patients (N). Representative gene sets are labeled with a red outline. p < 0.05 was considered statistically significant. ROC, receiver operating characteristic; DCA, decision curve analysis. * p < 0.05, ** p < 0.01, *** p < 0.001.CC BY · PubMed Central
Figure 10 Relationship of the prognostic panel with immune-predicting factors and autophagy-related genes. (A,B) The risk model was significantly negatively linked with the infiltration of RMCs (p < 0.001). (C) The integration of risk score and RMC infiltration presents a great prognostic value (p < 0.001). (D) Waterfall plot illustrates the highly mutated genes. (E,F) The risk signature was significantly positively related to the TMB (p < 0.001). (G) OS curves of the high- and low-TMB patients. (H) The combination of the risk score and the TMB presents a significant prognostic value (p < 0.001). (I) The distinct expression of representative immune checkpoint genes in high- and low-risk patients. (J) Circle diagram exhibits the correlation among the prognostic panel, RMCs, TMB, and immune checkpoint genes. Scatter plot displays the relationship between RGS19 and the risk score (K), CFB (L), PPP1R18 (M), and TOM1L1 expression (N). p < 0.05 was considered statistically significant. TMB, tumor mutation burden.
Figure 10 Relationship of the prognostic panel with immune-predicting factors and autophagy-related genes. (A,B) The risk model was significantly negatively linked with the infiltration of RMCs (p < 0.001). (C) The integration of risk score and RMC infiltration presents a great prognostic value (p < 0.001). (D) Waterfall plot illustrates the highly mutated genes. (E,F) The risk signature was significantly positively related to the TMB (p < 0.001). (G) OS curves of the high- and low-TMB patients. (H) The combination of the risk score and the TMB presents a significant prognostic value (p < 0.001). (I) The distinct expression of representative immune checkpoint genes in high- and low-risk patients. (J) Circle diagram exhibits the correlation among the prognostic panel, RMCs, TMB, and immune checkpoint genes. Scatter plot displays the relationship between RGS19 and the risk score (K), CFB (L), PPP1R18 (M), and TOM1L1 expression (N). p < 0.05 was considered statistically significant. TMB, tumor mutation burden.CC BY · PubMed Central
Figure 11 Construction of the nomogram and the predictive power of the RMC-based signature in immunotherapy response. Univariate (A) and multivariate (B) Cox regression analyses identified the pathological stage, M stage, age, and risk score as independent prognostic factors. (C) A nomogram was established according to the selected independent prognostic factors. The calibration diagram (D) and ROC curve (E) show the performance of the nomogram in predicting prognosis after 1, 3, and 5 years. (F–I) The differing sensitivity of the high- and low-risk patients subjected to anti-PD-1 and anti-CTLA-4 immunotherapy. (J) The proportions of patients who responded to anti-PD-L1 immunotherapy in the high- and low-risk groups in the IMvigor210 dataset. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease. (K) The ability of the risk score model to predict anti-PD-L1 immunotherapy response. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, no significance.
Figure 11 Construction of the nomogram and the predictive power of the RMC-based signature in immunotherapy response. Univariate (A) and multivariate (B) Cox regression analyses identified the pathological stage, M stage, age, and risk score as independent prognostic factors. (C) A nomogram was established according to the selected independent prognostic factors. The calibration diagram (D) and ROC curve (E) show the performance of the nomogram in predicting prognosis after 1, 3, and 5 years. (F–I) The differing sensitivity of the high- and low-risk patients subjected to anti-PD-1 and anti-CTLA-4 immunotherapy. (J) The proportions of patients who responded to anti-PD-L1 immunotherapy in the high- and low-risk groups in the IMvigor210 dataset. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease. (K) The ability of the risk score model to predict anti-PD-L1 immunotherapy response. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, no significance.CC BY · PubMed Central
Figure 12 Validation of the expression of three key DMA-RMSGs using IHC. The differential protein levels of CFB (A), PPP1R18 (B), and TOM1L1 (C) between normal and ccRCC tissues. IHC staining revealed the distinct expression patterns of CFB (D), PPP1R18 (E), and TOM1L1 (F) between the nondistant metastasis and distant metastasis samples. The positive cells of CFB (G), PPP1R18 (I), and TOM1L1 (K) between normal and ccRCC tissues. The positive cells of CFB (H), PPP1R18 (J), and TOM1L1 (L) between the nondistant metastasis and distant metastasis samples. ** p < 0.01, *** p < 0.001; ns, no significance. DMA-RMSGs, distant metastasis-associated resting mast-cell-sensitive genes; IHC, immunohistochemistry.
Figure 12 Validation of the expression of three key DMA-RMSGs using IHC. The differential protein levels of CFB (A), PPP1R18 (B), and TOM1L1 (C) between normal and ccRCC tissues. IHC staining revealed the distinct expression patterns of CFB (D), PPP1R18 (E), and TOM1L1 (F) between the nondistant metastasis and distant metastasis samples. The positive cells of CFB (G), PPP1R18 (I), and TOM1L1 (K) between normal and ccRCC tissues. The positive cells of CFB (H), PPP1R18 (J), and TOM1L1 (L) between the nondistant metastasis and distant metastasis samples. ** p < 0.01, *** p < 0.001; ns, no significance. DMA-RMSGs, distant metastasis-associated resting mast-cell-sensitive genes; IHC, immunohistochemistry.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 20

Metadata

Authors
Su, Y., Zhang, T., Lu, J., Qian, L., Fei, Y., Zhang, L., Fan, S., Zhou, J., Tang, J., Chen, H., & Liang, C.
Affiliations
  • Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China
  • Shanghai Jiao Tong University (CN)
  • University of Oxford (GB)
  • Anhui Medical University (CN)
Corresponding author
Chen, Haige
Venue
Cells
Publisher
MDPI AG
Published
2023-01-01
Volume
12
Issue
1
Pages
180
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4313472298
Cited by
20
References
64
Citations by year
2026: 3 · 2025: 3 · 2024: 10 · 2023: 4
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Anhui Medical University Basic and Clinical Cooperative Research Promotion Project (2020xkjT031, 202110366035, 2017ZHYX02)
  • National Level Innovation Training Program for Chinese College Students of the Ministry of Education of the People’s Republic of China (2020xkjT031, 202110366035, 2017ZHYX02)
  • Scientific Research Foundation of the Institute for Translational Medicine of Anhui Province (2020xkjT031, 202110366035, 2017ZHYX02)
Topics
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords
clear cell renal cell carcinoma, resting mast cells, distant metastasis, prognostic gene panel, immunotherapy response prediction, tumor-infiltrating immune cells, CFB, tumor mutational burden, anti-PD-1, anti-CTLA-4, PD-L1 inhibitors, immune heterogeneity, risk stratification
MeSH terms
Carcinoma, Carcinoma, Renal Cell, Humans, Immunotherapy, Kidney Neoplasms, Mast Cells, Prognosis, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. https://app.cochat.ai/papers/10.3390/cells12010180
The paper
Su, Y., Zhang, T., Lu, J., Qian, L., Fei, Y., Zhang, L., Fan, S., Zhou, J., Tang, J., Chen, H., & Liang, C. (2023). Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response. Cells. https://doi.org/10.3390/cells12010180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.